ÇÁ·Î±×·¥
½Ã°£ | Á¦¸ñ | ¡¡ | ¿¬ÀÚ | ¼Ò¼Ó |
---|---|---|---|---|
08:25~08:30 | ȸÀå Àλ縻 | ±èÇüö | ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸ Àå |
|
08:30~09:00 | Cutting edge technology of medical industry | ÁÂÀå | ¹ÚÇظ° | Â÷ÀÇ°ú´ë |
Devicor Medical Korea | Mammotome | |||
BD Korea | Encore | |||
RF medical | MWA | |||
STARmed | RFA | |||
»ï¼º¸Þµð½¼ | ÃÊÀ½ÆÄ | |||
Alpinion | ÃÊÀ½ÆÄ | |||
Session 1. Ç÷°ü ÃÊÀ½ÆÄ | ÁÂÀå | À±»ó¼· ¹Ú±âÇõ |
°¡Å縯ÀÇ´ë ´ë±¸°¡Å縯ÀÇ´ë |
|
09:00~09:20 | Diagnosis and management of acute or recurrent deep vein thrombosis | ¹®±âÀ± | °¡Å縯ÀÇ´ë | |
09:20~09:40 | The role of ultrasound in surveillance and follow-up of abdominal aortic aneur | ¸ðÇýÁø | ¼¿ïÀÇ´ë | |
09:40~10:00 | Importance of ultrasound in selection and obtaining vascular access | ±è¹ÌÁø | ÀüºÏÀÇ´ë | |
10:00~10:20 | Use of ultrasound in diagnosis and management of chronic venous disease | À±»óö | ¼øõÇâÀÇ´ë | |
10:20~10:40 | Ultrasonographic differential diagnosis of leg edema or pain | äÁö¿ø | ¼¿ïÀÇ´ë ¿µ»óÀÇÇаú |
|
10:40~10:50 | Q&A | |||
10:50~11:10 | Coffee Break | |||
11:10~12:00 | Session 2. ±¸¿¬¹ßÇ¥ | ÁÂÀå | À±ÇöÁ¶ ¹Ú¼øö |
ÀüºÏÀÇ´ë °¡Å縯ÀÇ´ë |
11:10~11:20 | Á÷Àå¾Ï T º´±â ¹× ¸²ÇÁÀý ÀüÀÌ Áø´Ü¿¡¼ DRE, ERUS, Rectal MRIÀÇ À¯¿ë¼º Æò°¡ | Á¤±Ô¼º | °¡Å縯ÀÇ´ë | |
11:20~11:30 | À¯¹æÃÊÀ½ÆÄ ¿µ¿ª¿¡¼ÀÇ ÃֽŠ¸ð¹ÙÀÏ AI¸¦ ±â¹ÝÀ¸·Î ÇÑ ½Ç½Ã°£ °¨Áö ¹× °¨º° Áø´ÜÀÇ ÀÓ»óÀû¿ë: Ãʱâ ÀüÇâÀû Ÿ´ç¼º ¿¬±¸ | ÀÌÁö¿¬ | °æºÏÀÇ´ë | |
11:30~11:40 | Deep vein thrombosis screened by ultrasonography in hospitalized patients: A retrospective study | °íÁø | °íÇÏÀÌ¿Ü°úÀÇ¿ø | |
11:40~11:50 | Safety and feasibility of ultrasound-guided placement of peripherally inserted central catheter performed by trauma surgeon in trauma intensive care unit: Preliminary study | Á¶Ç×ÁÖ | °¡Å縯ÀÇ´ë | |
11:50~12:10 | Special Lecture | ÁÂÀå | °Å¿ì | ºÎ»êÀÇ´ë |
AI ultrasound in the diagnosis of breast disease | ±è¿øÈ | °æºÏÀÇ´ë ¿µ»óÀÇÇаú |
||
12:10~13:00 | Lunch | |||
Session 3. À¯¹æ/°©»ó¼± ÃÊÀ½ÆÄ | ÁÂÀå | ¹ÚÈ£¿ë ¹ÚÈñºØ |
°æºÏÀÇ´ë ¹ÚÈñºØ¿Ü°úÀÇ¿ø |
|
13:00~13:20 | Ultrasound guided intervention for breast lesions: wire localization and tissue marker insertion | °íÀº¿µ | ¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú |
|
13:20~13:40 | AI-enhanced breast imaging (ultrasound, mammography, MRI): Where are we and where are we heading? | ±èÀçÈ« | ´õ´õºíÀ¯ÀÇ¿ø | |
13:40~14:00 | Is vacuum assisted breast biopsy an alternative to surgical biopsy for definitive diagnosis of indeterminate pathological B3 lesions on core biopsy? | Àü¿µ»ê | ±¸º´¿ø | |
14:00~14:20 | Factors associated with malignant upgrade and subsequent breast cancer occurrence of papillary breast lesions diagnosed on core needle biopsy | Á¤¿µÁÖ | ´ë±¸°¡Å縯ÀÇ´ë | |
14:20~14:40 | Thyroid microcalcifications (punctate echogenic foci) without discrete nodules: clinical significance | ½ÅÀçÈ£ | °í·ÁÀÇ´ë ¿µ»óÀÇÇаú |
|
14:40~15:00 | Pitfalls in thyroid ultrasound guided FNA and core needle biopsy. Pathologist's perspective | ÀÌÇå°æ | ½Å¿øÀÇ·áÀç´Ü | |
15:00~15:20 | Q&A | |||
15:20~15:40 | Coffee Break | |||
Session 4. º¹ºÎ/´ëÀåÇ×¹®/ÁßȯÀÚ/±Ù°ñ°Ý ÃÊÀ½ÆÄ | ÁÂÀå | ¹ÚÀÏ¿µ Á¶Ç×ÁÖ |
°¡Å縯ÀÇ´ë °¡Å縯ÀÇ´ë |
|
15:40~16:00 | Easy and convenient ultrasound-guided peripheral nerve block for cervical region | Á¤Á¾ÇÊ | ±³ÇÏÁ¦ÀÏÀÇ¿ø | |
16:00~16:20 | Trauma ultrasound in the scene | À̱æÀç | °¡ÃµÀÇ´ë | |
16:20~16:40 | The role of ultrasound in the management of airway | ¹Ú½Å·ü | ¿µ³²ÀÇ´ë | |
16:40~17:00 | Shear wave elastography and fibroscan (transient elastography) for the assessment of liver stiffness in chronic liver disease | ÇÑÁö¿ø | °¡Å縯ÀÇ´ë | |
17:00~17:20 | Various targeting methods using ultrasound for the intrahepatic lesions | ÇÑÀǼö | °¡Å縯ÀÇ´ë | |
17:20~17:30 | Q&A | |||
17:30~18:00 | Çà¿î±Ç Ãß÷ & Æóȸ»ç |
Room A-1, A-2 | Room B-1, B-2 | |||||
½Ã°£ | ÁÖÁ¦ | °»ç | ¼Ò¼Ó | ÁÖÁ¦ | °»ç | ¼Ò¼Ó |
---|---|---|---|---|---|---|
09:00~09:50 | Á÷Àå Ç×¹® ÃÊÀ½ÆÄ I (5¸í) |
Àü¿µ¹Î | ¼¿ï¼Ûµµº´¿ø | Á÷Àå Ç×¹® ÃÊÀ½ÆÄ II (5¸í) |
À¯´Ï³ª | ¼ººó¼¾Æ®º´¿ø |
»óº¹ºÎ ÃÊÀ½ÆÄ I (5¸í) |
ÀÌÀç±æ | ÀÌÈÀÇ´ë | »óº¹ºÎ ÃÊÀ½ÆÄ II (5¸í) |
ÃÖÈ£Áß | °¡Å縯ÀÇ´ë | |
09:50~10:00 | coffee break | |||||
10:00~10:50 | »óº¹ºÎ ÃÊÀ½ÆÄ III (5¸í) |
±èÀϺÀ | ±èÀϺÀ³»°úÀÇ¿ø | Ãæ¼öµ¹±â ÃÊÀ½ÆÄ (5¸í) |
õ¿µ´ö | ÇÑ»ç¶ûº´¿ø |
Áß½ÉÁ¤¸Æ°ü »ðÀÔ¼ú (5¸í) |
±æÀº¹Ì | ¼º±Õ°üÀÇ´ë | ¿Ü»ó ÁßȯÀÚ ÃÊÀ½ÆÄ (5¸í) |
¹ÚÈƼº | °í·ÁÀÇ´ë | |
12:00~13:00 | Luncheon Symposium | |||||
13:00~14:00 | ÇÏÁöÁ¤¸Æ·ù ÃÊÀ½ÆÄ I (5¸í) |
±è±âÈ | Ǫ¸§¿Ü°úÀÇ¿ø | °æµ¿¸Æ ÃÊÀ½ÆÄ (5¸í) |
Á¤ÇõÀç | ºÎ»êÀÇ´ë |
14:00~15:00 | ÇÏÁöÁ¤¸Æ·ù ÃÊÀ½ÆÄ II (5¸í) |
¹Ú¿µÁØ | °¡Å縯ÀÇ´ë | µ¿Á¤¸Æ·ç ÃÊÀ½ÆÄ (5¸í) |
°íÁø | °íÇÏÀÌ¿Ü°ú |
15:00~15:30 | coffee break | |||||
15:30~16:30 | À¯¹æ ÃÊÀ½ÆÄ I (5¸í) |
ÀÌÀº°æ | ÀºÀ¯¿Ü°ú | °©»ó¼± & °æºÎ ÃÊÀ½ÆÄ I (5¸í) |
Àü±â¿ø | ¹ÚÈñºØ¿Ü°ú |
À¯¹æ ÃÊÀ½ÆÄ II (5¸í) |
¹®¼ÒÇâ | ¶ó¶óÀ¯¿Ü°ú | °©»ó¼± & °æºÎ ÃÊÀ½ÆÄ II (5¸í) |
È«Àç¿õ | Çöó¿ö¿©¼º¿Ü°ú | |
AI À¯¹æ ÃÊÀ½ÆÄ (5¸í) |
±è¿øÈ | °æºÏÀÇ´ë ¿µ»óÀÇÇаú |
||||
16:30-17:30 | VABB Mammotome (5¸í) |
½ÅÇõÀç | ÇѾçÀÇ´ë | Thyroid RFA I (5¸í) |
¾öÅÂÀÍ | ÇÏÀÌÀ¯¿Ü°ú |
VABB Encore (5¸í) |
±èµ¿¿ø | ´ë¸²¼º¸ðº´¿ø | Thyroid RFA II (5¸í) |
±è¶ó¹Ì | ±è¶ó¹ÌÀ¯¿Ü°ú | |
VABB Bexcore (5¸í) |
¹Î¼±¿µ | °æÈñÀÇ´ë | Thyroid Core Needle Biopsy (5¸í) |
°í½Â»ó | ¹ÚÈñºØ¿Ü°ú | |
VABB(ATEC, Hologic) (5¸í) |
¹ÚÈñ¼º | ºÎ»êÀÇ´ë | ||||
Breast Core Needle Biopsy (5¸í) |
ÀÌÈñ½Â | ±Â¸ð´×º´¿ø | Thyroid FNA (10¸í) |
À±ÇöÁ¶ ¹Ú¹ÎÈ£ |
ÀüºÏÀÇ´ë Àü³²ÀÇ´ë |